EUVIMEDAvasta EUVIMED
Übersichtsarbeit

Living Liver Donors With Obesity and Metabolic Risk: Review and Guidance on Donor Triage and Care

Hyosun Han, Kristina Rachel Chacko, Babak Orandi, Dagny E von Ahrens, Alexandra Shingina, Susan C Kim, Kymberly D Watt, AnnMarie Liapakis, NALLDIG Consortium

Clinical Transplantation · 2026-11 · 40 (11)

DOI: 10.1111/ctr.70681 ↗

At a glance

Übersichtsarbeit in Clinical Transplantation, published online on 2026-10-28. Written by Hyosun Han and 8 co-authors. Institution: Department of Medicine, USC Keck School of Medicine, Los Angeles, California, USA. Major MEDLINE topics: Living Donors, Liver Transplantation, Obesity, Triage. 65 references.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

With the increasing prevalence of obesity in the United States, potential living liver donors (LLDs) are similarly impacted. Historically, LLDs with obesity are deemed too high risk for donation due to concern for hepatic steatosis (HS) or post‐surgical complications. Evolving data show that obesity is not the absolute indicator of HS and metabolic risk. Instead, distribution of fat in the visceral area as well as body composition drive the risk for metabolic dysfunction associated steatotic liver disease (MASLD). Prior practice patterns of denial of obese LLDs with metabolic risk require a change in mindset from the liver transplant community with a thoughtful, individualized risk assessment of all LLDs. By losing weight utilizing various dietary and procedural strategies, these “gray zone” LLDs improve their metabolic risk profile and can move into a low risk “green zone”, thus expanding the donor pool. Little data exist whether “gray zone” LLDs who succeed in weight loss have long‐term consequences to their own health if they regain their weight or the clinical impact on their LDLT recipients. Ethical and financial questions remain as to the LDLT centers’ direct responsibility to maintaining donor health. Future studies evaluating interventions and outcomes are needed.

Subjects

MeSH terms (MEDLINE)

Living DonorsLiver TransplantationObesityTriageDonor SelectionPractice Guidelines as TopicHumansRisk FactorsPrognosisFatty Liver

Author keywords

complication: medical/metabolicdonors and donation: livingliver transplantation: living donormetabolic syndromeobesity

Authors and institutions

  • Department of Medicine, USC Keck School of Medicine, Los Angeles, California, USA.
  • Department of Medicine, Albert Einstein College of Medicine, New York, New York, USA.
  • Department of Surgery, NYU Grossman School of Medicine, New York, New York, USA.
  • Department of Surgery, Albert Einstein College of Medicine, New York, New York, USA.
  • Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
  • Department of Surgery, Abdominal Transplantation, USC Keck School of Medicine, Los Angeles, California, USA.

Cite

APA

Han, H., Chacko, K. R., Orandi, B., von Ahrens, D. E., Shingina, A., Kim, S. C., Watt, K. D., Liapakis, A., & NALLDIG Consortium (2026). Living Liver Donors With Obesity and Metabolic Risk: Review and Guidance on Donor Triage and Care. Clinical Transplantation, 40(11). https://doi.org/10.1111/ctr.70681

Vancouver

Han H, Chacko KR, Orandi B, von Ahrens DE, Shingina A, Kim SC, et al. Living Liver Donors With Obesity and Metabolic Risk: Review and Guidance on Donor Triage and Care. Clinical Transplantation. 2026;40(11). doi:10.1111/ctr.70681

BibTeX
@article{Han2026,
  author = {Han, Hyosun and Chacko, Kristina Rachel and Orandi, Babak and von Ahrens, Dagny E and Shingina, Alexandra and Kim, Susan C and Watt, Kymberly D and Liapakis, AnnMarie and NALLDIG Consortium, NALLDIG Consortium},
  title = {Living Liver Donors With Obesity and Metabolic Risk: Review and Guidance on Donor Triage and Care},
  journal = {Clinical Transplantation},
  year = {2026},
  volume = {40},
  number = {11},
  doi = {10.1111/ctr.70681}
}
Start for free →